Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 08, 2012 16:30 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences

CAMBRIDGE, Mass., Nov. 8, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
November 07, 2012 08:00 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Reports Third Quarter 2012 Financial Results

CAMBRIDGE, Mass., Nov. 7, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
October 18, 2012 16:48 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Date of Third Quarter 2012 Financial Results Conference Call

CAMBRIDGE, Mass., Oct. 18, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
August 30, 2012 17:00 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences

CAMBRIDGE, Mass., Aug. 30, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
August 08, 2012 16:01 ET | Source: Momenta Pharmaceuticals

Momenta to Present at the Canaccord Genuity 32nd Annual Growth Conference

CAMBRIDGE, Mass., Aug. 8, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
August 03, 2012 16:56 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Acknowledges Federal Circuit Opinion Supporting Order Issued January 26, 2012 in Ongoing Suit Against Amphastar Pharmaceuticals and Watson Pharmaceuticals

CAMBRIDGE, Mass., Aug. 3, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
August 02, 2012 08:00 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Reports Second Quarter 2012 Financial Results

CAMBRIDGE, Mass., Aug. 2, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
July 16, 2012 08:00 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Date of Second Quarter 2012 Financial Results Conference Call

CAMBRIDGE, Mass., July 16, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
July 02, 2012 08:30 ET | Source: Momenta Pharmaceuticals

First Patient Dosed With M402 in Phase 1/2 Clinical Trial in Metastatic Pancreatic Cancer

CAMBRIDGE, Mass., July 2, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
June 22, 2012 21:02 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Decision in Teva Patent Litigation

CAMBRIDGE, Mass., June 22, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...